Billionaire Profile
Massimiliana Landini Aleotti & family
Global Rank
#405

Image: Unsplash Contributor | Unsplash License | via Unsplash

Massimiliana Landini Aleotti & family

CEO, Pharmaceuticals
ITALY
Real-Time Net Worth
$8.715B
Estimated based on Pharmaceuticals stock value as of April 20, 2026
0% (24h)
Age
83
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
ITALY

Biography

Massimiliana Landini Aleotti, born in 1942, is an Italian billionaire businesswoman and heiress. She and her family control the Menarini Group, one of Italy's largest pharmaceutical companies, which she inherited with her children after her husband's passing in 2014. Under her leadership, Menarini has expanded globally, with a significant presence in 140 countries. Her career has been marked by her strategic vision, leading the company through acquisitions, including Stemline Therapeutics, to bolster its oncology portfolio. Massimiliana Landini Aleotti has also been involved in philanthropic efforts, particularly in healthcare initiatives and supporting pediatric networks. As of March 2026, her net worth is estimated to be $9.2 billion, reflecting the ongoing success of the privately held enterprise.

Fact Checked
Verified by Editorial Team
Live Data
Updated 4/20/2026

Wealth Over Time

In-Depth Profile

Early Life

Massimiliana Landini Aleotti was born on August 7, 1942, in Lerici, Italy. Details about her upbringing and family dynamics remain relatively private.

Rise to Success

Massimiliana Landini Aleotti's career is closely tied to the Menarini Group, an Italian pharmaceutical company. In 2014, after the death of her husband, Alberto Aleotti, Massimiliana and her three children inherited control of the family-owned Menarini Group. Her husband, Alberto, had expanded the company into a global player. Massimiliana's daughter, Lucia Aleotti, serves as the chairman of the company, and her son, Alberto Giovanni, holds the position of vice chairman.

Key Business Strategies

Under the family's leadership, Menarini has continued to grow and expand. The company operates in 140 countries and has 18 manufacturing sites worldwide. Menarini has made key acquisitions, such as Berlin-Chemie in 1992 and Stemline Therapeutics in 2020, to bolster its portfolio. The company reported revenue of nearly €4.9 billion in 2025.

Philanthropy

Massimiliana Landini Aleotti and her family have channeled philanthropic efforts through the Menarini Group, particularly to support COVID-19 relief in Italy. The Menarini Group converted a production line to manufacture disinfectant gel and donated over 1 million surgical and FFP2 masks. They have also prioritized pediatric healthcare networks and supported social housing projects.

Career Milestones

1964

Family involvement in Menarini

Alberto Aleotti, her late husband, began working at Menarini.

1990s

Purchase of Menarini

Alberto Aleotti bought the company.

2011

Leadership Transition

Her daughter Lucia became chairman, and her son Alberto Giovanni became vice chairman.

2014

Inheritance

Massimiliana and her children inherited the Menarini Group.

Philanthropy & Social Impact

Healthcare

COVID-19 Relief

null

Menarini manufactured disinfectant gel and donated masks during the pandemic.

Healthcare

Pediatric Healthcare

null

Supporting pediatric networks like the Tommasino Bacciotti Foundation.

Social Services

Social Housing Renovation

null

Refurbishing housing units for families in need.

Controversies & Challenges

2013

Tax Evasion Accusations

Accused of tax evasion by Italian authorities.